The report delivers a strategic analysis of the global biopharmaceutical logistics market and growth forecast for the period from 2012 - 2020f. The Scope: of the report includes segmental analysis based on the type of transport used, and also based on type of product. It also covers geographical analysis of the market with growth forecast for the period of 2012 - 2020f. The geographic analysis section covers the market in North America, Europe, Asia-Pacific and the Rest of the World. The Porter’s Five Forces analysis is also included in the report provides an insight into market dynamics and industry competition.
A top-down approach was used to estimate the global bio-pharmaceutical logistics market by transport mode, and by product type. The values were cross-validated by using a bottom-up approach while estimating the market geographically. Service offerings of all the key and emerging players were mapped. We reviewed the key players’ product literature, annual reports, press releases, investor relations and relevant documents to gain market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.
The report also includes growth strategies and entry barriers to be considered. The report also includes competitive profiling of leading players, recent corporate developments in the industry and various business strategies adopted by them. This report will help players in the global pharmaceutical logistics market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies.
The company profile section includes detailed analysis of some of the key players such as Deutsche Post DHL Group, FedEx Corporation, Panalpina World Transport Ltd., and United Parcel Services, Inc.
1.1 Research Scope And Description
1.1 Global Bio-Pharmaceutical Logistics: Market Segmentation
1.2 Research Methodology
2. EXECUTIVE SUMMARY
3. QUALITATIVE ANALYSIS
3.1 Bio-Pharmaceutical Logistics Market Overview
3.1 Market Drivers
3.2 Market Challenges
3.2 Value Chain Analysis
3.3 Porter’s Five Forces Analysis: Global Bio-Pharma Logistics Market
3.2.1 Bargaining Power Of Suppliers
3.2.2 Bargaining Power Of Buyers
3.2.3 Threat Of New Entrants
3.2.4 Threat Of Substitutes
3.2.5 Competitive Rivalry
3.4 Competitive Landscape
4. GLOBAL BIO-PHARMACEUTICAL LOGISTICS MARKET, 2012 - 2020F
4.1 Market Overview
4.2 Global Bio-Pharmaceutical Logistics Market Analysis, By Mode Of Transport
4.2.1 Cold-chain logistics
4.2.2 Non-Cold Chain Logistics
4.3 Global Bio-Pharmaceutical Logistics Market, By Product Type
4.3.1 Generic Drugs Logistics
4.3.2 Branded Drugs Logistics
4.4 Global Biopharma Logistics Market, By Geography
4.4.1 North America
4.4.4 Rest of the World
5. COMPANY PROFILES
5.1 Deutsche Post DHL Group
5.2 FedEx Corporation
5.3 Panalpina World Transport (Holding) Ltd.
The global pharmaceutical market has more than doubled in the past ten years and is expected to reach 942 billion by the end of 2016. Patent rights for several leading drugs are set to expire, meaning that large portion of sales will shift from original brand manufacturer to generic manufacturers. Similar to other sectors, the pharmaceutical industry is also undergoing a geographic shift in its production facilities and sales. Markets like Asia, Latin America, Middle East, China, etc. are becoming imore attractive to these pharmaceutical companies, however, these markets are considered as the most challenging in terms of supply chain.
At present, the distribution structure in the European and American markets is heavily inclined towards national warehouses both regionally and centrally. Developing warehouse structures and outsourcing to logistics service providers is the a key focus in some pharmaceutical manufacturers. Low cost and greater visibility in the supply chain are the main advantages of outsourcing logistics services and is becoming an integral part of strategy.
The primary driving factor for the growth of this market include strict regulations in the form of Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP), which summarize the criteria relating to the purchase, storage and export of medicines. In addition, factors like increasing demand for temperature sensitive pharmaceutical products and delivery methods could contribute to the growth of this market.
Resricting factors include issues related to confidentiality of the proprietary information, loss of control and deteriorating services.
Geographically, Asia-Pacific dominates the market, which is evident from the presence of key players, and lower logistics costs.
Panalpina, DHL, FedEx and UPS are amongst the leading logistic service providers in the industry. The global market for bio-pharmaceutical logistics was valued at USD 61.1 billion in 2014 and is expected to reach USD 91.0 billion by 2020f, growing at a CAGR of 6.9% during the forecast period of 2015e to 2020f.